Cellular and Molecular Aspects of Dyssynchrony and Resynchronization

Jonathan A. Kirk, David A. Kass

Research output: Contribution to journalReview article

Abstract

Dyssynchronous contraction of the ventricle significantly worsens morbidity and mortality in patients with heart failure (HF). Approximately one-third of patients with HF have cardiac dyssynchrony and are candidates for cardiac resynchronization therapy (CRT). The initial understanding of dyssynchrony and CRT was in terms of global mechanics and hemodynamics, but lack of clinical benefit in a sizable subgroup of recipients who appear otherwise appropriate has challenged this paradigm. This article reviews current understanding of these cellular and subcellular mechanisms, arguing that these aspects are key to improving CRT use, as well as translating its benefits to a wider HF population.

Original languageEnglish (US)
Pages (from-to)29-41
Number of pages13
JournalHeart Failure Clinics
Volume13
Issue number1
DOIs
StatePublished - Jan 1 2017

Fingerprint

Cardiac Resynchronization Therapy
Heart Failure
Hemodynamics
Morbidity
Mortality

Keywords

  • Animal models
  • Cardiac resynchronization therapy
  • Dyssynchrony
  • Myocyte
  • Myofilament

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Cellular and Molecular Aspects of Dyssynchrony and Resynchronization. / Kirk, Jonathan A.; Kass, David A.

In: Heart Failure Clinics, Vol. 13, No. 1, 01.01.2017, p. 29-41.

Research output: Contribution to journalReview article

Kirk, Jonathan A.; Kass, David A. / Cellular and Molecular Aspects of Dyssynchrony and Resynchronization.

In: Heart Failure Clinics, Vol. 13, No. 1, 01.01.2017, p. 29-41.

Research output: Contribution to journalReview article

@article{9ded417ce96e44a190ff857a4d13fabe,
title = "Cellular and Molecular Aspects of Dyssynchrony and Resynchronization",
abstract = "Dyssynchronous contraction of the ventricle significantly worsens morbidity and mortality in patients with heart failure (HF). Approximately one-third of patients with HF have cardiac dyssynchrony and are candidates for cardiac resynchronization therapy (CRT). The initial understanding of dyssynchrony and CRT was in terms of global mechanics and hemodynamics, but lack of clinical benefit in a sizable subgroup of recipients who appear otherwise appropriate has challenged this paradigm. This article reviews current understanding of these cellular and subcellular mechanisms, arguing that these aspects are key to improving CRT use, as well as translating its benefits to a wider HF population.",
keywords = "Animal models, Cardiac resynchronization therapy, Dyssynchrony, Myocyte, Myofilament",
author = "Kirk, {Jonathan A.} and Kass, {David A.}",
year = "2017",
month = "1",
doi = "10.1016/j.hfc.2016.07.003",
volume = "13",
pages = "29--41",
journal = "Heart Failure Clinics",
issn = "1551-7136",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - Cellular and Molecular Aspects of Dyssynchrony and Resynchronization

AU - Kirk,Jonathan A.

AU - Kass,David A.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Dyssynchronous contraction of the ventricle significantly worsens morbidity and mortality in patients with heart failure (HF). Approximately one-third of patients with HF have cardiac dyssynchrony and are candidates for cardiac resynchronization therapy (CRT). The initial understanding of dyssynchrony and CRT was in terms of global mechanics and hemodynamics, but lack of clinical benefit in a sizable subgroup of recipients who appear otherwise appropriate has challenged this paradigm. This article reviews current understanding of these cellular and subcellular mechanisms, arguing that these aspects are key to improving CRT use, as well as translating its benefits to a wider HF population.

AB - Dyssynchronous contraction of the ventricle significantly worsens morbidity and mortality in patients with heart failure (HF). Approximately one-third of patients with HF have cardiac dyssynchrony and are candidates for cardiac resynchronization therapy (CRT). The initial understanding of dyssynchrony and CRT was in terms of global mechanics and hemodynamics, but lack of clinical benefit in a sizable subgroup of recipients who appear otherwise appropriate has challenged this paradigm. This article reviews current understanding of these cellular and subcellular mechanisms, arguing that these aspects are key to improving CRT use, as well as translating its benefits to a wider HF population.

KW - Animal models

KW - Cardiac resynchronization therapy

KW - Dyssynchrony

KW - Myocyte

KW - Myofilament

UR - http://www.scopus.com/inward/record.url?scp=84996939148&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84996939148&partnerID=8YFLogxK

U2 - 10.1016/j.hfc.2016.07.003

DO - 10.1016/j.hfc.2016.07.003

M3 - Review article

VL - 13

SP - 29

EP - 41

JO - Heart Failure Clinics

T2 - Heart Failure Clinics

JF - Heart Failure Clinics

SN - 1551-7136

IS - 1

ER -